Skip to main content
. 2022 Jul 7;39(7):587–595. doi: 10.1007/s40266-022-00959-6

Table 2.

Number (%) of subjects reporting at least one adverse event

Adverse event Total
[n = 137]
Dose 1
[n = 137]
Dose 2
[n = 137]
Any event 30 (21.9) 15 (10.9) 22 (16.1)
Severe event 8 (5.8) 6 (4.4) 3 (2.2)
Type
 Local events
  Pain at the injection site 5 (3.6) 2 (1.5) 3 (2.2)
  Redness 6 (4.4) 2 (1.5) 4 (2.9)
  Swelling 5 (3.6) 2 (1.5) 3 (2.2)
 Systemic events
  Vomiting 1 (0.7) 1 (0.7)
  Diarrhea 2 (1.5) 2 (1.5)
  Headache 10 (7.3) 7 (5.1) 3 (2.2)
  Fatigue 18 (13.1) 7 (5.1) 15 (10.9)
  Muscle pain 2 (1.5) 1 (0.7) 2 (1.5)
  Joint pain 2 (1.5) 2 (1.5)
  Other 3 (2.2) 2 (1.5) 1 (0.7)
  Fever 17 (12.4) 4 (2.9) 17 (12.4)

Data are expressed as n (%)